NR4A1 and diabetes mellitus: Furthermore, they concluded that microsomal PTGES-2 promotes aging of β-cells and their hypofunction via the PGE/EP3/NR4A1 axis, and drug blocking of microsomal PTGES-2 might have a therapeutic effect on aging-induced beta cellular hypofunction and diabetes (28).